Influenza Approved Articles & Analysis
1 articles found
For example, MF59 is safe and well tolerated, and the AS03 adjuvanted monovalent influenza A (H5N1) vaccine was approved in the US in 2013. In addition, some new vaccine adjuvants are being studied for use in various vaccine formulations, such as TLR agonists, immune checkpoint inhibitors, nanoparticle adjuvants, combination adjuvants, and nucleic acid adjuvants, ...
